Clover Health Investments Corp (CLOV)
$3.06
0.03 (0.83%)
CLOV Stock Quote Delayed 30 Minutes
Clover Health Is Risky But Offers a Healthy Upside Ahead
Clover Health's robust fourth quarter and upbeat guidance has improved the risk/reward opportunity of CLOV stock.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
300,703
Day's Range
$3.03 - $3.07
52-Week Range
$0.61 - $3.82
Dividend & Yield
N/A (N/A)
CLOV Stock Predictions, Articles, and Clover Health Investments Corp News
Clover Health Stock Will Be Your Lucky Four-Leaf Clover in 2022
CLOV stock is high-risk but potentially also high-reward as Clover Health rakes in the revenue and helps at-risk patients get healthcare.
What’s So Special About Clover Health?
As many underserved U.S. seniors seek affordable healthcare, CLOV stock is transforming an entire industry through data and technology.
Sell Clover Health Stock in the Wake of Its Rally
CLOV stock recently enjoyed a considerable relief rally. However, its fundamentals remain as poor as ever and its gains will be fleeting.
Clover Health: Praying to the Great Google
Clover Health lacks the scale to succeed, although its Clover Assistant software is intriguing.
Is Clover Stock a Buy Right Now? Its 160% Revenue Growth Says Yes.
Off and on the price chart, CLOV stock is heading towards a better tomorrow and has much less to do with recent meme-driven news.
Why Is Clover Health (CLOV) Stock Up Today?
Clover Health is trading higher after director Chelsea Clinton disclosed a 100,000 share purchase. Who else is betting big on CLOV stock?
Here’s the One Thing That Could Make or Break Clover Health Stock
Clover Health and CLOV stock rest in the hands of its direct contracting (DC) business. A new model could hinder or help its business.
Recent Results Signal Clover Stock Is a Worthy High-Risk Wager
As the situation for Clover Health may not be as bad as once feared, now may be the time to buy hard-hit former meme favorite CLOV stock.
Surprising Global Optimism Could Help Clover Health Stock Recover
Due to the worrying geopolitical flashpoint, CLOV stock seemed far too risky. But an unexpected hero may change everything.
Is CLOV Stock a Buy at 52-Week Lows? 3 Analysts Weigh In on Clover Health.
Here's what some expert analysts think about Clover Health and CLOV stock amid the stock's impressive decline to new 52-week lows.
A Buyout May Be the Best Hope for Clover Health Now
The situation behind CLOV stock is spiraling from bad to worse. A sale of the company may be the only option to keep Clover Health running.
CLOV Stock Price Predictions: Why One Analyst See Clover Health Shares Hitting $7
Clover Health Investments (CLOV) stock is on the move Wednesday following a new price prediction from Cowen analyst Gary Taylor.
At Below $3 Clover Health Stock May Be Worth It as a Moonshot
With CLOV stock, it may be worth rolling the dice at today's prices.
Clover Health Stock Remains a High-Risk High-Reward Play
Both Clover Health's bear and bull cases are equally compelling, which makes CLOV stock a highly risky bet right now.
Membership Growth Is Making Clover Health a More Convincing Investment
You can hold CLOV stock in hopes of another Reddit run-up, but there are also positive data points to support a long-term investment.
Clover Health Stock Investors Will Need to Buy Into Tech Chief’s Vision
CTO Andrew Toy's innovations like Clover Assistant, seen by some as savior of CLOV stock, are already being adopted by larger Medicare Advantage players.
Clover Health Desperately Needs Triage, but It Isn’t Doomed Yet
Clover Health has a billion dollar yearly book of sales. Selloffs have limits, and we will soon find out if CLOV stock is a dud or a stud.
CLOV Stock Alert: 4 Things to Know as Clover Health Hits an All-Time Low
Shares of Clover Health are declining today due to Humana lowering its membership forecast and Credit Suisse issuing a downgrade.
